iOmx
iOmx Therapeutics, located in Martinsried, Germany, is a biopharmaceutical company focused on developing first-in-class cancer immuno-therapeutics addressing novel immune checkpoints hijacked by cancer cells.
Last updated on
About iOmx
Founded
2016Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$120MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
541Location
City
Martinsried/ MunichState
BavariaCountry
GermanyTech Stack (17)
